drugset / Trial / NCT01502124
Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to evaluate the safety profiles of Norditropin® (lyophilized somatropin) and Norditropin® cartridges (liquid somatropin) in children with growth hormone deficiency.
Timeline
- Start
- 2001-05-08
- Primary completion
- 2003-03-05
- Completion
- 2003-03-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 0.024 mg/kg | Subcutaneous |
| Subject | Somatropin | Protein / enzyme biologic | 0.05 mg/kg | Subcutaneous |